Advisor Group Holdings »

Acrivon Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $36k 5.1k 7.15

More positions owned by Advisor Group Holdings

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Sands Capital Ventures
Wellington Management Company
BlackRock
Marshall Wace
Vanguard Group
Geode Capital Management
State Street Corporation
DAFNA Capital Management
UBS O'Connor
Northern Trust
Renaissance Technologies
Millennium Management

View all funds holding Acrivon Therapeutics